Slideshows

Is oxidative stress a therapeutic target in schizophrenia?

Six patient types to watch for.

Hypertension, loss of sense of smell, personality changes: which can predict dementia?

This slideshow provides a snapshot of innovative alternatives to traditional treatments for psychiatric disorders.

Researchers investigate links between depression and exercise, childhood sexual abuse, and diet.

What are the strongest predictors of suicidality in schizophrenia?

Treatment nonadherence in psychiatric patients contributes to increased suicide rates, illness exacerbation, hospitalization, and mortality. This Special Report countdown highlights the psychiatrist’s role in addressing barriers to treatment in a number of scenarios.

The authors describe an alternative model for BPD diagnosis that is dimensional in nature and requires fulfillment of 4 of 7 personality traits.

A novel protocol lights the way for a promising treatment for bipolar depression.

The latest news in the treatment of depression covers patient self-management apps, antidepressant efficacy in older adults, and strategies to improve adherence.

Which is more important, for whom?

New tools for the armamentarium: a patient self-management app, a retinal imaging system, and a computer program for Alzheimer diagnosis.

Tips for having a balanced and comprehensive risk-to-benefit discussion with competent patients who want to stop their medications.

Is an effective, well-tolerated treatment for the negative symptoms of schizophrenia on the horizon?

Are you up-to-date on the latest findings in mild cognitive impairment, dementia, and depression in elderly patients?

New findings support the involvement of microbiota alterations in psychosis-and point to novel treatments.

Which psychotropic combinations unlock the door to successful treatment?

What factors predispose patients to TRD and what treatment strategies achieve response? Find out here, with a bonus case vignette.

Here is a rundown of 6 soon-to-expire free CME activities you can take right now.

Researchers investigate Alzheimer disease in 3 key areas: sleep, seizures, and proton pump inhibitors.

The authors compare the clinical features of idiopathic psychosis (eg, schizophrenia) with cannabis-induced psychosis.

A clinical collection on addiction treatment, ADHD and SUDs, important drug indications, vaping, cannabis use, benzodiazepines, the perils of self-medicating and other topics relevant to practicing psychiatrists.

Not just a nuisance, no-shows are an opportunity to turn things around for patients with bipolar disorder, whose treatment adherence hovers around 60%.

The main goal in treating addiction is to help the patient achieve and improve functioning. When that patient is also an adolescent, there are special considerations. Here's a quick primer.

Among the clues revealed in 3 recent studies: brain amyloid, saliva biomarkers, and microvascular dysfunction.

Which of these agents best prevents relapse? A recent study employed a novel approach to find out.

In psychiatry, hot debates abound if you just look around-and if this Special Report collection is any indication, the result is a balance of opinion and civility made richer by virtue of opposing views.

Most individuals who have experienced a disaster-related event or epidemic are at increased risk for distress behaviors that have equally significant and chronic consequences. Here’s what psychiatrists need to know.

Three new studies show exercise can improve cognitive function, psychotropics for PTSD may raise dementia risk, and 3 biomarkers can help predict cognitive decline in elderly persons.

Clinicians need to consider and manage multiple medical and cognitive comorbidities when working with the elderly population. This slideshow provides an overview of key points relevant to geriatric bipolar disorder as it relates to comorbidity.